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Improved Hematopoiesis in Anemic Sl/SP’ Mice by Splenectomy and Therapeutic
Transplantation of a Hematopoietic Microenvironment
By Pervin Anklesaria, T.J. FitzGerald, Kenneth Kase, Akira Ohara, and Joel S. Greenberger
The ability of a clonal hematopoiesis-supportive bone-
marrow stromal cell line GBlneor to engraft and alter the
microenvironment-induced anemia of SI/Sl’ mice was
studied. Prior to stromal cell transplantation. SI/SId mice
received 1 Gy total body irradiation (TBI) and 1 3 Gy to the
right hind limb. Two months after intravenous (IV) injection
of 5 x 1  GBlneor cells. 54.4% ± 1 7.0% donor origin
(G41 8’) colony-forming cells were recovered from the right
hind limb of SI/SId mice. Long-term bone marrow cultures
(LTBMCs) established from GBlneortransplanted mice
produced 1 89.5 CFU-GEMM-forming progenitors/flask
over 1 0 weeks compared with 52.7 ± 6.2 CFU-GEMM
forming progenitors /flask from irradiated nontransplanted
SI/Sld mice. A partial correction of macrocytic anemia was
detected 2 months after GBlneor transplantation in sple-
nectomized. irradiated SI/SId mice (HgB 7.2 ± 0.4 g/dL;
MCV 68.3 ± 7.0 fI) compared to splenectomized, irra-
diated, nontransplanted SI/SId mice (HgB 5.5 ± 1 .1 g/dL;
MCV 76 ± 8.5 fL) or control SI/SId mice (HgB 5.4 ± 0.5
g/dL; MCV 82.4 ± 1 .3 fI). Mean RBC volume distribution
A GENETICALLY determined defect in the bone-
marrow microenvironment of S//S/d mice results in a
deficiency of mature erythroid precursors and reduced num-
bers of pluripotential hematopoietic stem cells.’5 Ultrastruc-
tural analysis of the bone-marrow of Sl/Sl” mice shows a
reduction in overall cellularity.6’7 Sl/SId mice are not cured
by allogeneic or semiallogeneic stem-cell transplantation,
and spleens of irradiated mice have defective CFU-s colony
formation by marrow stem cells from normal donors.5 Long-
term bone marrow cultures (LTBMCs) established from
Sl/Sl’ mice show decreased cumulative production of hema-
topoietic progenitor cells compared with normal littermate
mice.8 X-irradiation of LTBMC stromal cells from Si/SI”
mice has been shown to restore some hematopoietic support
capacity.’2 Recent studies with permanent clonal stromal cell
lines derived from LTBMCs 0f51/S1d mice demonstrate that
some lines suppress hematopoiesis in vitro.9 The available
evidence supports the conclusion that abnormal hematopoie-
sis observed in 51/5ld mice is due to a defect in cells of the
hematopoietic microenvironment.
Several types of transplantation experiments have been
attempted as therapy for the 51151d anemia, including para-
biosis, transplantation of whole spleens, and implantation of
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analysis showed a 2.5-fold increase in percentage of
peripheral blood RBCs with MCV s45 fI and confirmed
reduction of the MCV in splenectomizedGBIneor_trans
planted mice compared to control SI/SId mice. A hemato-
poiesis-suppressive clonal stromal cell line derived from
LTBMCs of SI/Sid mice (SIdneo) engrafted as effectively
(43.5% ± 1 .2% G418t CFU-F/limb) as did GBlneo’ cells
(38.3% ± 0.16% G418’ CFU-F/limb) to the irradiated right
hind limbs of C57BI/6 mice. LTBMCs established after 2 or
6 months from SIdneortransplanted mice showed
decreased hematopoiesis (182 ± 12 [2 months] and
3494.3 ± 408.1 [6 months] CFU-GEMM forming progeni-
tors/flask over 10 weeks) compared to those established
from GBIneortranspIanted mice (5980 ± 530 [2 months]
and 7728 ± 607, [6 months] CFU-GEMM progenitors form-
ing/flask). Thus. transplantation of clonal bone-marrow
stromal cell lines in vivo can stably transfer their physio-
logic properties to normal or mutant mice.
S 1989 by Grune & Stratton. Inc.
normal mouse femurs into the abdominal wall.’3’5 An
increase in total cellularity and hematopoietic progenitors
was reported in one of these studies but with no significant
improvement in clinical macrocytic anemia)4 In the present
studies we used a technique for bone-marrow stromal cell
transplantation that involves total body irradiation (TB!)
and boost irradiation to an isolated extremity followed by
intravenous (IV) injection of a clonal-marrow stromal cell
line. The clonal bone-marrow stromal cell line GB1/6 derived
from LTBMCs has been shown to support hematopoietic
stem cells in vitro, engrafts to targeted marrow sites, and
supports hematopoietic recovery in vivo in sublethally irra-
diated normal mice.’6 We studied the effects of transplanta-
tion ofGBl/6 stromal cell line into 51151d recipient mice and
in a reciprocal experiment the effect of transplanting a
hematopoiesis-suppressive stromal cell line (S!”3) derived
from the Si/Sid mouse marrow microenvironment9 into nor-
mal mice. The data provide evidence for physiologic long-
term stability and thus the therapeutic potential of marrow
stromal-cell transplantation.
MATERIALS AND METHODS
Mice. Adult, 5- to 8-week-old, severely anemic WCB6F1 Sl/Sl”
mice and C57B1/6 mice were obtained from Jackson Laboratories,
Bar Harbor, ME. B6’Cast’-GPI-’a’ mice, obtained from iackson
Laboratories, were bred at the University of Massachusetts Medical
Center.
Bone-marrow stromal cell lines. Derivation and characteriza-
tion of clonal-marrow stromal cell lines (GBI/6, GBlneo’, S1d3,
+/+ 2.4 and D2XRII) have been described previously.9’6” The
embryo fibroblast cell line Bl/6embC was provided by Dr S.
Aaronson, NC!, Bethesda, MD. Neomycin (G418)-resistant sub-
clones of Sld3 and D2XRII and Bl/6embC were established by
retroviral vector-mediated gene transfer.17 The subclones are desig-
nated Sl”neo’, D2Xnec’, and Bl/6embneo’C, respectively.
Total body and hind-limb boost irradiation. Adult recipient
SI/SI” or C57B1/6 mice received I to 2 Gy TBI and 10.0 to 20.0 Gy
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Fig 1 . Stromal cell colonies (CFU-F) recovered from mice
receiving TBI (1 Gy) and boost irradiation (13 Gy) to the RHL of
control-nonirradiated (NR). irradiated adult C57BL/6 (#{149}).or SIISId
(El) mice. At time points indicated after irradiation. five mice were
killed from each group. Bone marrow cells were harvested.
washed. counted. and plated in duplicate at 1 x 1 Os and 5 x 10’
cells/60-mm dish. At day 14. CFU-F colonies (>50 cells) were
scored using an inverted microscope. Results are expressed as the
mean ± SD of CFU-F/hind limb. P < .05. compared with CFU-F
from NR C57BL/6 mice. and P < .05 compared with CFU-F from
NA 5,,5,d mice.
STROMAL CELL TRANSPLANT 1 145
to the right hind limb (RHL) or both hind limbs (BHL) delivered by
a linear accelerator as described.’6 We used I Gy TB! and 10 Gy to
the RHL due to the relative sensitivity of 51,51d mice to TBI.2
Irradiated mice were transplanted with 5 x l0 stromal cells of each
line (GBlneo’, Sldneor, Bl/6 embneorC or D2Xneo’) by IV injection
(single schedule). For sequential boost irradiation-transplantation
studies with Sl/Sld mice, I Gy TB! and 10 Gy to the RHL was
delivered by linear accelerator on day 0. A single-cell suspension of
the GBlneo’ cell line was injected IV 48 hours later. Two months
after the first irradiation schedule, the same group of mice received I
Gy TBI and 10 Gy to the left hind limb (LHL). Another injection of
the GBlnco’ cell line was administered 48 hours later (multiple
transplant schedule). Control irradiated nontransplanted mice
received 2 Gy TBI and 10 Gy to both hind limbs (BHL).
Splenectomy and irradiation 0f51/51d mice. Sl/Sld mice (5 to 6
weeks old) were anesthetized using an inhalation anesthetic me-
thoxyflurane (metofane, Pitman Moore, Inc, Washington Crossing,
Ni). A small incision was made in the flank region, and the spleen
was gently removed and cauterized as described.’4 The incision was
sutured with a 5.0 chromic gut and the skin flaps held together with
wound clips using Mikron auto clip (Clay Adams). Two weeks after
splenectomy, mice were irradiated (I Gy TBI and 10 Gy BHL) and
transplanted (single schedule) with the GBlneo’ marrow stromal cell
line as described above. Transplanted and control animals were
followed for clinical improvement of their sampled blood HgB
concentration, hematocrit, and mean corpuscular volume (MCV), as
described below.
Measurement of stromal cell engraftment. The CFU-F assay
was carried out as described.’6 Briefly, control-irradiated-nontrans-
planted or irradiated-transplanted mice were sacrificed at time
intervals indicated, and the harvested bone-marrow cells from each
hind limb were counted and plated at different cell concentrations in
60-mm dishes (Falcon, Lincoln Park, Ni) in the absence or presence
of 200 zg/mL G418 (Gibco). CFU-F colonies (>25 cells) were
counted at days 7 and 14.
Measurement of hematopoietic recovery in vivo and in
vitro. Peripheral blood from transplanted and control-irradiated---
nontransplanted mice was analyzed monthly. BLOOd from the tail
vein (80 tL) was collected in heparinized microhematocrit capillary
tubes (Fisher Scientific, Springfield, Ni) and mixed with 20 mL of
diluent (NaCI [6.38 g/LJ, Boric acid [I .0 g/L], sodium tetraborate
[0.2 g/LJ, and EDTA-2K [0.2 g/L]). RBCs, WBCs, platelets, HgB
concentration, hematocrit, and MCV were measured using an
automated TOA-II Sysmex Counter (American Scientific Products,
Stone Mountain, GA). Mean volume distribution studies of RBCs
obtained from control-irradiated-splenectomized and transplanted
mice were studied using a Coulter Counter with a Channalizer
(Coulter, Hialeah, FL). Peripheral blood smears were made and
stained with Wright’s-Giemsa stain.
The functional integrity of transplanted stromal cells was evalu-
ated by establishing LTBMCs from each hind limb as described.9”
Hematopoietic recovery was quantitated by measuring cumulative
nonadherent C FU-G EM M-forming progenitor cells removed
weekly for over I 0 weeks in culture.9”
In vitro hematopoietic progenitor cell engraftment to clonal
stromal cell lines. Plateau-phase cultures of each stromal cell line
(GBlneo’ or S/”neo’) were individually established by plating cells in
25 cm2 flasks (Corning Plastics, New York). The confluent stromal
cell cultures were engrafted with 2.5 to 3.0 x 10’ washed, nonadher-
ent hematopoietic progenitor cells harvested from 4- to 6-week-old
LTBMCs established from C57B1/6 mice.9 At weekly intervals after
engraftment, nonadherent cells were harvested and assayed for
CFU-GEMM-forming progenitor cells. Colony assays were per-
formed using pokeweed-mitogen-stimulated spleen cell-conditioned
medium (PWM-SCCM) and erythropoietin (EPO) as described.”
In other experiments, different ratios of the two stromal cell lines
were added to same flasks to test for dominance of biologic proper-
ties.
Statistical evaluation. The differences between the means was
determined by standard Student’s t test and chi-square analysis.9
RESULTS
Recovery ofbone-marrow stromal cells in vitro after TB!
and isolated hind-limb boost irradiation in vivo. The
effects of TBI (I to 2 Gy) and high-dose irradiation to the
RHL (I 3 Gy) on regeneration ofnormal C57B1/6 and Si/Si”
mouse-marrow stromal cells in vivo were studied first. Two
days following I Gy TB! and I 3 Gy to the RHL, the femoral
CFU-F from normal C57B1/6 mice decreased to 53% of the
level detected in control-nonirradiated mice (Fig 1 ). By 60
days after irradiation, a further decrease (26% of control) in
the colony-forming potential of marrow stromal cells from
irradiated C57B1/6 mice was observed (P < .05). Improve-
ment in the colony-forming ability of stromal cells from
irradiated mice at 1 80 days after irradiation was not signifi-
cant (Fig I).
The number of colony-forming CFU-F progenitors/hind
limb obtained from nonirradiated 51151d mice was 53% lower
than that of control nonirradiated C57BI/6 mice. At two
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Table 1 . Support of Hematopoietic Progenitors by Stromal Cell
Cultures Derived From Different Ratios of Sldneor and
GBlneo Clonal Cell Lines
Cel Lines Ratio PIat.d
Cumulative CFIJ-GEMM
Progenitors/Flask
Sldned 1 21.5 ± 2.5
GBLneo’ 1 1867 ± 218
1:1
1:10
1:50
1:100
33 ± 1.8
584.5 ± 8.5
555 ± 43.2
450±79.6
GBlneo’ 10:1 33.6 ± 6.7
Stromal cells plated at different ratios in 25-cm2 flasks in duplicate to
form confluent cultures with no further cell division possible, thus
maintaining a stable ratio. Day 36 nonadherent hematopoietic cells (3 x
io’ cells) from C57BL/6 LTBMCs were then enafted to each flask. At
weekly intervals. nonadherent cells produced/flask were harvested and
assayed for CFU-GEMM-forming progenitors.
tResults are expressed as mean ± SD day 34 cumulative CFU-
GEMM-forming progenitors/flask from two separate experiments.
days after irradiation, the number of CFU-F colonies
obtained from irradiated Si/Si” mice was not significantly
lower than that of control-nonirradiated Si/Si” mice. How-
ever, by 60 days after irradiation, there was a 4! % decrease
in the colony-forming ability of stromal cells from irradiated
Si/Si” mice (P < .05, Fig 1). These data indicated that the
schedule of TB! and boost irradiation would reduce the
number of colony-forming host stromal cells and should
provide space to support the seeding of engrafted stromal
cells at this site.
Support ofhema:opoietic progenitor ceiis by stromai cell
cuitures derived from different ratios of Sl”necf and
GBineo’. To estimate the number of GBlneor cells required
to overcome the suppressive marrow microenvironment of
si/sr’ mice, we first derived plateau-phase stromal cultures
in vitro from different ratios of Si(neor and GBlneor cells.
These mixed stromal-cell cultures were then engrafted with
day 40 hematopoietic progenitor cells from LTBMCs of Bl/6
mice. As shown in Table 1, cultures of 100% GBlneor cells
supported hematopoiesis for over 4 weeks. In contrast, cul-
tures of 100% Si(neor cell line supported 1% of the number of
progenitor cells compared to the GBlneo1 cell cultures
(P < .05). Plateau-phase cultures with equal numbers of
GBlneor and Si(neor cells (1 : 1) supported less than 2% of the
number of hematopoietic progenitors. The number of pro-
genitors supported by stromal cultures at a I :10 ratio of
GBlneoSineot was 2% of the level supported by cultures of
GBlneor cells (P < .05). Increasing the numbers of GBlneot
cells (tenfold, 50-fold, or I 00-fold) resulted in a 1 7% increase
in the number of CFU-GEMM-forming progenitors sup-
ported compared to the cultures containing equal numbers of
GBlneor and Sineot cells (Table 1). If the results with mixed
cultures in vitro were extrapolated to predict the results of
engrafting new stromal cells in vivo, then up to 80% of the
post-transplant hematopoietic microenvironment of Si/SI”
mice might have to be replaced by GBlneor cells to observe a
detectable biological effect.
Stromai ceii line transplantation in vivo improves hema-
topoiesis in splenectomized Sl/Sld mice. The ability of
GBlneor cells to stably engraft into irradiated Si/Si” mice
was first evaluated. Explanted marrow cells from control-
nontransplanted mice and GBlneo1-transplanted mice were
selected in 200 zg/mL G41 8. Two months after transplanta-
tion, 54.4% ± 17% of the stromal cell colonies obtained from
Si/Si” mice transplanted with GBlneor cell line were G4l&
and of donor origin (Table 2, group 2). Control-irradiated--
nontransplanted SI/Si” mice showed no detectable G4I8
adherent CFU-F (Table 2, group 4b). In comparison, the
number of GBlneor CFU-F recovered from irradiated trans-
planted Bl/6 mice at 2 months was 38.3% ± 0.16% of the
total recovered from the RHL (Table 2, group 1). Thus the
GBlneo cell line engrafted with equal efficiency to Si/Si” or
C57B1/6 mice. At 6 months after transplant, no donor origin
G4l8 CFU-F were detected in the RHL ofSi/Sl” recipients
Table 2. Recovery of Don or Origin Cells From Hind Limb Explants of Mice Transplanted With Clonal Stromal Cell Lines
Total No. of Stromal Total No. 04 18-Resistant Donor
O4#{149}
Cell Colonies Per Hind Limb Origin Stromal Cefi Colonies Per Hind Limbt
2mos 2mos 6mos
Right Left RiitRit Left
1. C57B1/6micetrans- 78.0 ± 13.0 98.7 ± 13.3 30 ± 2.0 10.3 ± 2.0 17.6 ± 16
plantedwithGBlneo’8.1 (38.3 ± 0.16) (9.9 ± 3.0) (22.5 ± 20)
cells
2. SI/SI”micetransplanted 182.4 ± 9.1 126.0 ± 47.0 99.3 ± 32 65.0 ± 36.0 0
withGBlneo’8.1 cells (54.4 ± 17.0) (51.6 ± 28.0)
3. C57B1/6cellsmicetrans- 88.5 ± 7.0 90.0 ± 20.3 38.5 ± 8.5 29.5 ± 10.4 7 ± 4
plantedwithS/”neo’3.3 (43.5 ± 1.2) (32.7 ± 1.2) (8 ± 4.5)
cells
4. Control-irracated-non- 65.5 ± 4.1 110.1 ± 10.3 0 0 0
transplanted
(a) (C57B1/6 mice) or 25.0 ± 5.0 NT 0 0 0
(b) (SI/Sid mice)
Abbreviation: NT, not tested.
#{149}TheC57B 1/6 mice received 3 Gy T8l and 1 3 Gy to the RHL; 5//5/d mice received 1 Gy TBl and 1 1 Gy to the RHL. Results are expressed as mean ±
SD for three to five animals/group.
tme values in parenthesis are % of the values obtained in cultures without G4 18.
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(Table 2, group 2). In contrast, at 6 months, 22.5% G41 8
CFU-F colonies were still detected in GBlneor transplanted
C57BI/6 mice (Table 2, group I).
The in vivo hematopoietic recovery of GBlneortrans
planted Si/Si” mice was next studied. Peripheral blood
counts from control-irradiated (I Gy TBI + 10 Gy RHL)-
nontransplanted Si/Si” mice were similar to those of nonirra-
diated 5//51d mice (Table 3, group II, III). Irradiated Si/Si”
mice transplanted with GBlneor cells (single schedule)
showed no significant recovery of the peripheral blood counts
at 60 days (Table 3, group IVa). Si/Si” mice receiving
sequential boost irradiation of both hind limbs and multiple
schedule transplants also showed no significant hemato-
poietic recovery in vivo at 120 days (Table 2, group IVb).
To determine whether the failure to achieve detectable
hematopoietic recovery in the GBlneortransplanted mice
was attributable to the inability of these cells to overcome the
suppressive microenvironment of the Si/Si” anemia, we next
repeated the transplant studies in splenectomized Si/Si”
mice. A group of Si/Si” mice were splenectomized 1 5 days
before TB! and hind-limb irradiation (10 Gy BHL) and were
then transplanted with the GBlneor cell line. Splenectomized,
irradiated, GBlneortransplanted mice had significantly in-
creased WBC counts and Hgb concentration (9.5 ± 1 .4 x
!O3fitL and 7.2 ± 0.4 g/dL, respectively [Table 3, group V])
at 2 months, compared with nonirradiated Si/Si” mice
(WBC counts: 4.6 ± 0.6 x !03/isL; Hgb concentration:
5.4 ± 0.5 g/dL, Table 3, group III P < .05). The splenec-
tomized GBlneortransplanted mice at 2 months had reduced
MCV (68.3 ± 7.0 fL) compared with that from control mice
(82.4 ± I .3 if.; P < .05, Table 3, group II). RBC volume
distribution analysis demonstrated clear differences in RBC
volumes comparing Si/Si” mice to normal C57B1/6 mice,
with only a small overlap between the two populations (Fig
2). The median MCV for normal RBCs from C57B1/6 mice
was 30 fL (range 16 to 45 fL) and that for Si/Si” mice was 78
ff (range 52 to 83 fL; Fig 2). In the peripheral blood RBC
population obtained from splenectomized G Blneortrans
planted Si/Si” mice, there was a 2.5- and I .5-fold increase in
the percentage of cells with MCV of 45 fL and 52 fL
respectively as compared with those obtained from Si/Si”
mice (Fig 2). This shift in red cell volume to normal levels
suggests a detectable partial correction of the macrocytic
anemia in vivo in GBlneoT transplanted mice.
The physiologic function of GBlneor cells in different
groups of transplanted Si/Si” mice was next evaluated by in
vitro culture of marrow. The first group consisted of mice
receiving lGy TB! and 13 GY to the RHL. Marrow cultures
established from irradiated-nontransplanted Si/Si” mice
showed increased cumulative progenitor cell production per
flask (RHL, 10 Gy; 52 ± 10 progenitors/flask) compared to
those from nonirradiated control mice (1 6 ± 4 progenitors/
flask; P < .01; Fig 3). The cumulative number of nonadher-
ent CFU-GEMM-forming progenitors produced in
LTBMCs from RHL (10 Gy) ofGBlneor transplanted Si/Si”
mice was I 89.5 progenitors/flask. This was higher than that
produced either in LTBMCs irom control-nonirradiated or
control- i rradiated-nontransplanted mice. In contrast,
LTBMCs established from the left hind limb of transplanted
mice (1 Gy) supported multipotential progenitor cell produc-
tion less efficiently (46.5 CFU-GEMM forming progeni-
tors/flask; Fig 3). In the next two groups tested, we
attempted to replace a dominant fraction of the marrow
microenvironment ofSi/Si” mice by preparing the mice with
either 2 Gy TB! and 20 Gy to both hind limbs (BHL, single
schedule) or by sequential irradiation transplantation (multi-
ple schedule), as described in Materials and Methods. In
both experiments none of the control-irradiated-nontrans-
planted mice survived. LTBMCs established from GBlneor
transplanted mice (2 Gy TB! and 20 Gy BHL) at 4 months
showed increased cumulative CFU-GEMM-forming pro-
genitors/flask in both right (298.8 ± 32.7) and left
(4! 5.8 ± 36.5) hind limb cultures compared to nonirradiated
Sl/Sl” mice (P < .05; Fig 4). In separate experiments, 2
months after mice received the second irradiation transplan-
tation, the cumulative number of CFU-GEMM-forming
progenitors obtained per flask was higher in LTBMCs
established from engrafted RHL (136.! ± 32) and LHL
(78.6 ± 1 5.4) of GBlneo1-transplanted mice compared with
those from control-nonirradiated Si/Si” mice (P < .05; Fig
Table 3. Hematopoietic Recovery at Two Months in SI/Sid Mice Transplanted With GBlneo’ Cells
Peripheral BI ood Analysis
wBC RBC PLT HgB lICT MCV
G014,#{149} X i03/pL x 1O’/L x iO4iL g/dL % (FL)
I. NormalC57Bl/6 7.5 ± 1.7 8.1 ± 0.2 514 ± 145 12.1 ± 0.4 35.4 ± 6.6 36.6 ± 4.4
II. NonirradiatedSl/SId 4.6 ± 0.67 2.1 ± 0.2 234.9 ± 70.2 5.4 ± 0.5 17.5 ± 1.2 82.4 ± 1.3
Ill. lrradiated-nontransplantedSl/S/” 4.5 ± 0.7 2.9 ± 0.1 142 ± 5 6.6 ± 0.1 20.8 ± 0.15 71 ± 2
IV. SI/Si” transplanted with GBlneor
a) At6Odays(RHL) 4.3 ± 0.5 2.57 ± 0.37 411 ± 200 6.0 ± 1.1 18.1 ± 3.4 70 ± 2.9
b) At l2odays(BHL)t 3.26 ± 0.5 1.9 ± 0.57 153.3 ± 53 4.9 ± 1.6 17.0 ± 6.0 86.6 ± 7.5
V. Si/SI” splenectomized and trans-
plantedwithGBlneo’(BHL) 9.5 ± 1.4 3.15 ± 0.2 152.6 ± 43.4 7.2 ± 0.4 19.1 ± 3.8 68.3 ± 7.0
VI. 51/51d splenectomized irradiated
nontransplanted 7.6 ± 1.9 2.24 ± 0.6 201.3 ± 118.0 5.5 ± 1.1 16.6 ± 3.5 76 ± 8.5
Results are expressed as mean ± SD for at least three to five mice per group.
tIn group (b) mice received sequential irradiation-transplantation (multiple schedule). and all control-irradiated-nontransplanted mice died within 15
days after second wradiation.
P < .05 as compared to control-nontransplanted SI/SI” mice.
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Peripheral blood from normal C57BL/6 (s), SI/SI’
(0). splenectomized GBlneo’-transplanted SI/SId
( D ), and
planted SI/SI” (0) mice at 4 months was diluted
1:10.000 and run at 1 1/amp and 1/2 1/current
setting of a Coulter Counter. MCV (fL) was esti-
mated using standard latex particles
(d = 3.l4Mmol/L). Results are expressed as mean
1 6 30 45 52 78 88 1 02 ± SD percentage of total cells counted. At least
five mice were analyzed per group. P..05 com-
MCV ( fI ) pared with control SI/S1’ mice.
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4). Thus the transplanted GBlneor cells functioned both in
vivo in splenectomized Si/Si” mice to support hematopoiesis
and in vitro after explant to LTBMC.
Transpiantation of the Slaneor stromai cell line to irra-
diated C57BL/6 mice. Normal C57B1/6 mice that received
TB! and RHL irradiation (1 Gy TB! and 10 Gy RHL) were
transplanted with the Sldneor stromal cell line. At 2 and 6
months after transplantation, adherent stromal cells
explanted from femurs and tibias of transplanted mice were
selected in G41 8, and the percentage of donor-origin stromal
cells recovered was 43.5% ± 1 .2% and 8% ± 4.5% respec-
tively (Table 2, group 3). Thus the Sidneor cell line engrafted
in vivo to Bl/6 mice as efficiently as the GblneoT cell line
(Table 2, group 1). Marrow cultures established from mice
transplanted with the GBlneoT stromal cell line had signifi-
cantly higher CFU-GEMM-forming progenitors per flask
(2 months 5980 ± 530; 6 months 7728 ± 607, P < .05) com-
pared with those from either control-irradiated-nontrans-
planted orSineortransplanted mice (Fig 5). In contrast, the
cumulative number of hematopoietic progenitors supported
by LTBMCs established at 2 and 6 months post-transplanta-
tion from Sidneor transplanted mice was 182 ± 12 and
3494 ± 408 CFU-GEMM progenitors/flask, respectively,
and was no higher than that detected with marrow cultures
Fig 3. Hematopoiesis in LTBMCs established
from hind limbs of irradiated and GBLneo’-trans-
planted SI/SId mice. At 2 months after transplant.
LTBMCs were established from RHL and LHL of
three to five mice per group of control-nonirra-
diated S,/S,d mice (-0-); irradiated-nontrans-
planted RHL-10 GY (-G-); and LHL-1 Gy
(-0-). GBlneo’ transplanted RHL-10 Gy
(-#{149}-). and LHL-1 Gy (-R--). Results are
expressed as mean ± SD of cumulative CFU-
GEMM progenitors/flasks.
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Fig 4. Support of hematopoietic progenitors
harvested from LTBMCs established from SI/SId
mice after 2 Gy TBI and 20 Gy to BHL (single
schedule) or 1 Gy TBI and 10 GY RHL followed by a
second irradiation dose of 1 Gy TBI and 10 Gy IHI
2 months later (multiple transplant schedule). At 4
months after irradiation-transplantation. LTBMCs
were established from three mice/group. Control.
nonirradiated 5,/51d mice (-0-). GBlneo’ trans-
planted RHL-20 Gy (-G-). LHL-20 GY (-0-).
sequentially irradiated GBlneo’-transplanted RHL-
10 Gy (-#{149}-). and LHL-10 Gy (--). Results
are expressed as mean ± SD of cumulative, nonad-
herent CFU-GEMM progenitors/flask.
established from control-irradiated-nontransplanted mice
(219 ± 9 [2 months] and 3225 ± 363 [6 months] CFU-
GEMM-forming progenitors/flask; Fig 5). Thus both the
GBlneor and Sldneor cells transferred their in vitro biologic
properties to the in vivo marrow microenvironment of
C57B1/6 mice.
DISCUSSION
The present studies demonstrate that the GBlneor marrow
stromal cell line engrafts in vivo and improves hematopoietic
recovery in splenectomized Si/Si” mice. Another stromal cell
line, Sldneor, does not support hematopoiesis in vitro but
DAYS IN CULTURE
engrafts in vivo and transfers its biologic properties to
irradiated C57B1/6 mice. Thus distinct physiologic proper-
ties of two clonal stromal cell lines that are expressed in vitro
are maintained following transplantation in vivo.
The engrafted GBlneor cells in splenectomized irradiated
Si/Si” mice induced an increase in the HgB concentration as
well as WBC counts in the peripheral blood of these mice as
compared to that of control or splenectomized mice. The
present data confirm and extend a previous report that
demonstrated a partial stimulation of erythropoiesis in sple-
nectomized Si/Si” mice implanted with intact spleens from
+ I + mice.’4 A decrease in the average MCV of peripheral
z
w
S
a-
w
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Fig 5. Hematopoietic progenitors produced in
LTBMCs established from the RHLs of Sldneor and
GBlneor transplanted C57BL/6 mice. At 2 and 6
months after transplantation. three to five mice
per group were sacrificed and LTBMCs established
from RHL. Results are expressed as mean ± SD
cumulative. nonadherent CFU-GEMM progenitors/
flask from control-irradiated-nontransplanted
mice at 2 (-#{149}--) and 6 (-U-) months. from
GBlneortransplanted mice at 2 (-0-) and 6
60 70 (-0-) months; and from SIneortransplanted
mice at 2 (-#{149}-) and 6 (-A-) months.
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blood RBCs was also observed in splenectomized GBlneor
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